Literature DB >> 28501461

Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer.

Yingwei Li1, Haiyang Guo2, Chengjuan Jin1, Chunping Qiu1, Min Gao1, Lei Zhang3, Zhaojian Liu4, Beihua Kong5.   

Abstract

Ovarian cancer is the most lethal gynecologic malignancy and the molecular pathogenesis of high-grade serous ovarian carcinoma has not been completely characterized. Numerous studies have shown that altered splicing patterns and splicing factors were found to contribute to tumor development and progression. In this study, we demonstrated that spliceosome-associated factor CTNNBL1 was significantly upregulated in high-grade serous ovarian carcinoma, the elevated level of CTNNBL1 indicates poor prognosis in patients with high-grade serous ovarian carcinoma. Functional characterization revealed that CTNNBL1 promoted the proliferation and invasion of ovarian cancer cells in vitro. Furthermore, through transcriptome analysis, we found CTNNBL1 regulates multiple splicing events and gene expression in ovarian cancer cells. Importantly, we identified IFI16 and FOXM1 splicing was regulated by CTNNBL1. To our knowledge, this is the first study exploring the expression, functional roles and regulated splicing events of CTNNBL1 in ovarian cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative splicing; CTNNBL1; EMT; HGSOC; Invasion; Prognosis

Mesh:

Substances:

Year:  2017        PMID: 28501461     DOI: 10.1016/j.yexcr.2017.05.008

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  The Roles of Drug Metabolism-Related ADH1B in Immune Regulation and Therapeutic Response of Ovarian Cancer.

Authors:  Zhijie Xu; Bi Peng; Fanhua Kang; Wenqin Zhang; Muzhang Xiao; Jianbo Li; Qianhui Hong; Yuan Cai; Wei Liu; Yuanliang Yan; Jinwu Peng
Journal:  Front Cell Dev Biol       Date:  2022-06-09

2.  Integrated bioinformatics analysis of validated and circulating miRNAs in ovarian cancer.

Authors:  Berkcan Dogan; Ece Gumusoglu; Ege Ulgen; Osman Ugur Sezerman; Tuba Gunel
Journal:  Genomics Inform       Date:  2022-06-30

3.  The origin of exosomal miR-1246 in human cancer cells.

Authors:  Yi-Fan Xu; Bethany N Hannafon; Ujjwol Khatri; Amy Gin; Wei-Qun Ding
Journal:  RNA Biol       Date:  2019-03-23       Impact factor: 4.652

4.  Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma.

Authors:  Silin Jiang; Xiaohan Ren; Shouyong Liu; Zhongwen Lu; Aiming Xu; Chao Qin; Zengjun Wang
Journal:  Front Genet       Date:  2021-02-12       Impact factor: 4.599

5.  Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma.

Authors:  Yunsong Chen; Yan Lu; Yanli Ren; Jupeng Yuan; Nasha Zhang; Hannah Kimball; Liqing Zhou; Ming Yang
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

6.  ONECUT2 is a driver of neuroendocrine prostate cancer.

Authors:  Haiyang Guo; Xinpei Ci; Musaddeque Ahmed; Junjie Tony Hua; Fraser Soares; Dong Lin; Loredana Puca; Aram Vosoughi; Hui Xue; Estelle Li; Peiran Su; Sujun Chen; Tran Nguyen; Yi Liang; Yuzhe Zhang; Xin Xu; Jing Xu; Anjali V Sheahan; Wail Ba-Alawi; Si Zhang; Osman Mahamud; Ravi N Vellanki; Martin Gleave; Robert G Bristow; Benjamin Haibe-Kains; John T Poirier; Charles M Rudin; Ming-Sound Tsao; Bradly G Wouters; Ladan Fazli; Felix Y Feng; Leigh Ellis; Theo van der Kwast; Alejandro Berlin; Marianne Koritzinsky; Paul C Boutros; Amina Zoubeidi; Himisha Beltran; Yuzhuo Wang; Housheng Hansen He
Journal:  Nat Commun       Date:  2019-01-17       Impact factor: 14.919

Review 7.  Function and Regulation of Nuclear DNA Sensors During Viral Infection and Tumorigenesis.

Authors:  Fan Zhang; Yi Yuan; Feng Ma
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

8.  Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.

Authors:  Shourong Wang; Zixiang Wang; Jieyin Li; Junchao Qin; Jianping Song; Yingwei Li; Ling Zhao; Xiyu Zhang; Haiyang Guo; Changshun Shao; Beihua Kong; Zhaojian Liu
Journal:  Cell Death Dis       Date:  2021-03-17       Impact factor: 8.469

9.  Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1.

Authors:  Chen Zhao; Yingwei Li; Chunping Qiu; Jingying Chen; Huan Wu; Qiuman Wang; Xinyue Ma; Kun Song; Beihua Kong
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

10.  Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients.

Authors:  Marianna Buttarelli; Alessandra Ciucci; Fernando Palluzzi; Giuseppina Raspaglio; Claudia Marchetti; Emanuele Perrone; Angelo Minucci; Luciano Giacò; Anna Fagotti; Giovanni Scambia; Daniela Gallo
Journal:  J Exp Clin Cancer Res       Date:  2022-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.